Publications in the Year: 2023

Journal Article

Hassab LY, Abbas SS, Mohammed RA, Abdallah DM.  2023.  Dimethyl fumarate abrogates striatal endoplasmic reticulum stress in experimentally induced late-stage Huntington’s disease: Focus on the IRE1α/JNK and PERK/CHOP trajectories. Frontiers in Pharmacology. 14:1133863.
Samra AI, Kamel AS, Abdallah DM, Fattah MAEA, Ahmed KA, El-Abhar HS.  2023.  Preclinical Evidence for the Role of the Yin/Yang Angiotensin System Components in Autism Spectrum Disorder: A Therapeutic Target of Astaxanthin. Biomedicines. 11((12)):3156.
Mohamed OE, Abdallah DM, Fayez AM, Mohamed RA, El-Abhar HS.  2023.  Morin post-treatment surpassed calpeptin in ameliorating 3-NP-induced cortical neurotoxicity via modulation of glutamate/calpain axis, Kidins220, and BDNF/TrkB/AKT/CREB trajectory. Int Immunopharmacol .. 116:109771.
Zaky DA, Abdallah DM, El-Abhar HS.  2023.  Intranasal Exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: Role of mTORC1 in immunogenic and tolerogenic cell demise. Eur J Pharmacol. 961:176191.
Hamed AB, El-Abhar HS, Abdallah DM, Ahmed KA, Abulfadl YS.  2023.  Prunetin in a GPR30-dependent manner mitigates renal ischemia/reperfusion injury in rats via interrupting indoxyl sulfate/TLR4/TRIF, RIPK1/RIPK3/MLKL, and RIPK3/PGAM5/DRP-1 crosstalk. Saudi Pharm J. 31((11)):101818.
Abdallah DM, Kamal MM, Aly NES, El-Abhar HS.  2023.  Anandamide modulates WNT-5A/BCL-2, IP3/NFATc1, and HMGB1/NF-κB trajectories to protect against mercuric chloride-induced acute kidney injury. Sci Rep. 13((1)):11899.
Tourism